Improvements to pharmaceutical manufacturing capacity, Ethiopia
Kedir Tahir Hagos, Tsige Gebre-Mariam, David Woo, Abraham Gebregiorgis Kahsay, Mengistab Woldearegay Teferi, Jicui Dong · 2026
Read Improvements to pharmaceutical manufacturing capacity, Ethiopia by Kedir Tahir Hagos, Tsige Gebre-Mariam, David Woo, Abraham Gebregiorgis Kahsay, Mengistab Woldearegay Teferi, Jicui Dong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13626530.txt.
Description
Kedir Tahir Hagos and co-authors report on Ethiopia's decade-long push to make more of its own medicines, in a 2026 paper. Heavy reliance on imports left the country open to shortages and currency strain. In 2015 the government launched a ten-year strategy joining health and industry ministries, with World Health Organization support. Tools included factory incentives, favored public buying, and stronger regulation.
By 2025, eleven makers were running and six plants met national quality rules. The drug regulator reached a solid maturity grade, and local coverage of the essential medicines list grew. A vaccine plant initiative also began. Yet home supply reached only about a quarter of demand, far under the target. Raw material imports and money gaps held progress back, and the authors list the next priorities plainly.
Catalog record
| CREATOR | Kedir Tahir Hagos, Tsige Gebre-Mariam, David Woo, Abraham Gebregiorgis Kahsay, Mengistab Woldearegay Teferi, Jicui Dong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |